A. Mayweg

1.2k total citations
19 papers, 576 citations indexed

About

A. Mayweg is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, A. Mayweg has authored 19 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 6 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in A. Mayweg's work include Synthetic Organic Chemistry Methods (6 papers), Computational Drug Discovery Methods (3 papers) and Synthesis of Organic Compounds (3 papers). A. Mayweg is often cited by papers focused on Synthetic Organic Chemistry Methods (6 papers), Computational Drug Discovery Methods (3 papers) and Synthesis of Organic Compounds (3 papers). A. Mayweg collaborates with scholars based in Switzerland, United Kingdom and United States. A. Mayweg's co-authors include Jack E. Baldwin, Gareth J. Pritchard, Paul A. Wender, Michael K. Hilinski, Robert M. Adlington, Zhiheng Xu, Taishan Hu, Zheng Zhou, Hong C. Shen and Zhisen Zhang and has published in prestigious journals such as Cancer Research, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

A. Mayweg

19 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Mayweg Switzerland 13 308 189 117 115 43 19 576
Carl Berthelette Canada 19 428 1.4× 200 1.1× 84 0.7× 29 0.3× 32 0.7× 25 705
Katja Hübel Germany 12 486 1.6× 255 1.3× 73 0.6× 24 0.2× 28 0.7× 13 696
Panagiota Moutevelis‐Minakakis Greece 14 296 1.0× 345 1.8× 49 0.4× 36 0.3× 84 2.0× 28 554
Brianne S. Raccor United States 13 237 0.8× 198 1.0× 151 1.3× 80 0.7× 12 0.3× 21 505
Ravi Naik South Korea 11 190 0.6× 264 1.4× 60 0.5× 27 0.2× 17 0.4× 20 529
Francis G. Fang United States 19 743 2.4× 416 2.2× 209 1.8× 63 0.5× 30 0.7× 38 1.2k
Nicolas Lebègue France 13 340 1.1× 351 1.9× 73 0.6× 16 0.1× 23 0.5× 54 680
Dietmar Rakowitz Austria 11 209 0.7× 142 0.8× 47 0.4× 145 1.3× 14 0.3× 24 428
Brian Heasley United States 12 294 1.0× 351 1.9× 50 0.4× 39 0.3× 18 0.4× 14 637
Chandrakant Bagul India 15 512 1.7× 333 1.8× 54 0.5× 32 0.3× 39 0.9× 30 700

Countries citing papers authored by A. Mayweg

Since Specialization
Citations

This map shows the geographic impact of A. Mayweg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Mayweg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Mayweg more than expected).

Fields of papers citing papers by A. Mayweg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Mayweg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Mayweg. The network helps show where A. Mayweg may publish in the future.

Co-authorship network of co-authors of A. Mayweg

This figure shows the co-authorship network connecting the top 25 collaborators of A. Mayweg. A scholar is included among the top collaborators of A. Mayweg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Mayweg. A. Mayweg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Zhisen, Zheng Zhou, Zhiheng Xu, et al.. (2023). Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus. Journal of Medicinal Chemistry. 66(20). 14116–14132. 5 indexed citations
2.
O’Connor, Matthew, Theodore Nicolaides, Jie Zhang, et al.. (2019). Abstract LB-111: Epidermal growth factor receptor oncogenes expressed in glioblastoma are activated as covalent dimers and exhibit unique pharmacology. Cancer Research. 79(13_Supplement). LB–111. 2 indexed citations
3.
Jiang, Min, Zheng Zhou, Zhiheng Xu, et al.. (2017). Discovery of potent and selective CDK8 inhibitors through FBDD approach. Bioorganic & Medicinal Chemistry Letters. 27(18). 4488–4492. 24 indexed citations
4.
Martin, Rainer E., Johannes Lehmann, Johannes D. Aebi, et al.. (2016). Synthesis of annulated pyridines as inhibitors of aldosterone synthase (CYP11B2). Organic & Biomolecular Chemistry. 14(25). 5922–5927. 28 indexed citations
5.
Neidhart, Werner, Tanja Schulz‐Gasch, A. Ruf, et al.. (2015). Challenges and Rewards in Medicinal Chemistry Targeting Cardiovascular and Metabolic Diseases. CHIMIA International Journal for Chemistry. 69(7-8). 407–407. 1 indexed citations
6.
Martin, Rainer E., Johannes D. Aebi, Bernd Kuhn, et al.. (2015). Discovery of 4-Aryl-5,6,7,8-tetrahydroisoquinolines as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors: In Vivo Evaluation in Rodents and Cynomolgus Monkeys. Journal of Medicinal Chemistry. 58(20). 8054–8065. 35 indexed citations
7.
Zhang, Zhisen, Zhaohu Lin, Zheng Zhou, et al.. (2014). Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein Interaction. ACS Medicinal Chemistry Letters. 5(9). 993–998. 134 indexed citations
8.
Woltering, Thomas J., Wolfgang Wostl, Hans Hilpert, et al.. (2013). BACE1 inhibitors: A head group scan on a series of amides. Bioorganic & Medicinal Chemistry Letters. 23(14). 4239–4243. 43 indexed citations
9.
Craig, Donald C., et al.. (2011). Transannular Claisen rearrangement reactions for the synthesis of vinylcyclobutanes: formal synthesis of (±)-grandisol. Organic & Biomolecular Chemistry. 9(23). 8000–8000. 7 indexed citations
10.
Mayweg, A., Urs Hofer, Patrick Schnider, et al.. (2011). ROCK: the Roche medicinal chemistry knowledge application – design, use and impact. Drug Discovery Today. 16(15-16). 691–696. 15 indexed citations
11.
Craig, Donald C., et al.. (2010). Transannular, decarboxylative Claisen rearrangement reactions for the synthesis of sulfur-substituted vinylcyclopropanes. Chemical Communications. 46(27). 4991–4991. 18 indexed citations
14.
Wender, Paul A., Michael K. Hilinski, & A. Mayweg. (2004). Late-Stage Intermolecular CH Activation for Lead Diversification:  A Highly Chemoselective Oxyfunctionalization of the C-9 Position of Potent Bryostatin Analogues. Organic Letters. 7(1). 79–82. 78 indexed citations
15.
Wender, Paul A., et al.. (2003). A Concise, Selective Synthesis of the Polyketide Spacer Domain of a Potent Bryostatin Analogue. Organic Letters. 5(3). 277–279. 24 indexed citations
16.
Baldwin, Jack E., A. Mayweg, Gareth J. Pritchard, & Robert M. Adlington. (2003). Expedient synthesis of a highly substituted tropolone via a 3-oxidopyrylium [5+2] cycloaddition reaction. Tetrahedron Letters. 44(24). 4543–4545. 26 indexed citations
17.
Adlington, Robert M., Jack E. Baldwin, A. Mayweg, & Gareth J. Pritchard. (2002). Biomimetic Cycloaddition Approach to Tropolone Natural Products via a Tropolone Ortho-quinone Methide. Organic Letters. 4(17). 3009–3011. 57 indexed citations
18.
Baldwin, Jack E., Robert M. Adlington, Fanny Roussi, et al.. (2001). Studies towards the biomimetic synthesis of the nonadrides CP-225,917 and CP-263,114. Tetrahedron. 57(34). 7409–7416. 15 indexed citations
19.
Baldwin, Jack E., et al.. (1999). Studies toward the Biomimetic Synthesis of Tropolone Natural Products via a Hetero Diels−Alder Reaction. Organic Letters. 1(12). 1933–1935. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026